Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis
Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized)...
Gespeichert in:
Veröffentlicht in: | American journal of respiratory and critical care medicine 1999-09, Vol.160 (3), p.796-801 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 801 |
---|---|
container_issue | 3 |
container_start_page | 796 |
container_title | American journal of respiratory and critical care medicine |
container_volume | 160 |
creator | STITES, S. W PLAUTZ, M. W BAILEY, K O'BRIEN-LADNER, A. R WESSELIUS, L. J |
description | Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p < 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p < 0.005) or NS (9 +/- 3 ng/ml, p < 0.0005). Ferritin recovered from HS and NS lungs was < 2% H type, whereas ferritin in CF lungs was > 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth. |
doi_str_mv | 10.1164/ajrccm.160.3.9811018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70009621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70009621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</originalsourceid><addsrcrecordid>eNpNkMtqHDEQRYWJ8Sv5gxC0CNn1pKoldbeWweRhMHgTQ3ZCrZawTI80UWlw5u8jMwPJSgU691J1GHuPsEEc5Gf7XJzbbnCAjdjoCRFwOmNXqITqpB7hTZthFJ2U-tcluyZ6BsB-QrhglwhyRKX1Fftzl1zxlvzCXU7Op1psjTkRz4HHkhO3aeGRcvClxBrbR0y8Pnm-5hdfePG0iy2Sy4G3qKuvuV2raE3EX2J94lTtvHruDlSj4yHOJVOkt-w82JX8u9N7wx6_ff15-6O7f_h-d_vlvnNC9LXzQk9SLTAI5XCxutcaQc9Tj6Gf9KRhnAGXWQk7KHChHT8NTgYRpgH7ZZTihn069u5K_r33VM02kvPrapPPezIjAOihxwbKI-jaflR8MLsSt7YcDIJ5NW6Oxk0zboQ5GW-xD6f-_bz1y3-ho-IGfDwBlpxdQ7HJRfrHaaXGAcVfTDiMdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70009621</pqid></control><display><type>article</type><title>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</title><source>Journals@Ovid Complete - AutoHoldings</source><source>MEDLINE</source><source>American Thoracic Society Journals</source><source>EZB Electronic Journals Library</source><creator>STITES, S. W ; PLAUTZ, M. W ; BAILEY, K ; O'BRIEN-LADNER, A. R ; WESSELIUS, L. J</creator><creatorcontrib>STITES, S. W ; PLAUTZ, M. W ; BAILEY, K ; O'BRIEN-LADNER, A. R ; WESSELIUS, L. J</creatorcontrib><description>Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p < 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p < 0.005) or NS (9 +/- 3 ng/ml, p < 0.0005). Ferritin recovered from HS and NS lungs was < 2% H type, whereas ferritin in CF lungs was > 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/ajrccm.160.3.9811018</identifier><identifier>PMID: 10471599</identifier><language>eng</language><publisher>New York, NY: American Lung Association</publisher><subject>Adult ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - chemistry ; Bronchoalveolar Lavage Fluid - cytology ; Cell Count ; Chronic Disease ; Cystic Fibrosis - metabolism ; Enzyme-Linked Immunosorbent Assay ; Female ; Ferritins - metabolism ; Humans ; Iron - metabolism ; Male ; Medical sciences ; Pneumology ; Proteins - metabolism ; Respiratory system : syndromes and miscellaneous diseases ; Smoking - adverse effects ; Statistics, Nonparametric ; Transferrin - metabolism ; Tumor Cells, Cultured - metabolism ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>American journal of respiratory and critical care medicine, 1999-09, Vol.160 (3), p.796-801</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</citedby><cites>FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4011,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1955761$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10471599$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STITES, S. W</creatorcontrib><creatorcontrib>PLAUTZ, M. W</creatorcontrib><creatorcontrib>BAILEY, K</creatorcontrib><creatorcontrib>O'BRIEN-LADNER, A. R</creatorcontrib><creatorcontrib>WESSELIUS, L. J</creatorcontrib><title>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p < 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p < 0.005) or NS (9 +/- 3 ng/ml, p < 0.0005). Ferritin recovered from HS and NS lungs was < 2% H type, whereas ferritin in CF lungs was > 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Bronchoalveolar Lavage Fluid - cytology</subject><subject>Cell Count</subject><subject>Chronic Disease</subject><subject>Cystic Fibrosis - metabolism</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Ferritins - metabolism</subject><subject>Humans</subject><subject>Iron - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pneumology</subject><subject>Proteins - metabolism</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Smoking - adverse effects</subject><subject>Statistics, Nonparametric</subject><subject>Transferrin - metabolism</subject><subject>Tumor Cells, Cultured - metabolism</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMtqHDEQRYWJ8Sv5gxC0CNn1pKoldbeWweRhMHgTQ3ZCrZawTI80UWlw5u8jMwPJSgU691J1GHuPsEEc5Gf7XJzbbnCAjdjoCRFwOmNXqITqpB7hTZthFJ2U-tcluyZ6BsB-QrhglwhyRKX1Fftzl1zxlvzCXU7Op1psjTkRz4HHkhO3aeGRcvClxBrbR0y8Pnm-5hdfePG0iy2Sy4G3qKuvuV2raE3EX2J94lTtvHruDlSj4yHOJVOkt-w82JX8u9N7wx6_ff15-6O7f_h-d_vlvnNC9LXzQk9SLTAI5XCxutcaQc9Tj6Gf9KRhnAGXWQk7KHChHT8NTgYRpgH7ZZTihn069u5K_r33VM02kvPrapPPezIjAOihxwbKI-jaflR8MLsSt7YcDIJ5NW6Oxk0zboQ5GW-xD6f-_bz1y3-ho-IGfDwBlpxdQ7HJRfrHaaXGAcVfTDiMdw</recordid><startdate>19990901</startdate><enddate>19990901</enddate><creator>STITES, S. W</creator><creator>PLAUTZ, M. W</creator><creator>BAILEY, K</creator><creator>O'BRIEN-LADNER, A. R</creator><creator>WESSELIUS, L. J</creator><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990901</creationdate><title>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</title><author>STITES, S. W ; PLAUTZ, M. W ; BAILEY, K ; O'BRIEN-LADNER, A. R ; WESSELIUS, L. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Bronchoalveolar Lavage Fluid - cytology</topic><topic>Cell Count</topic><topic>Chronic Disease</topic><topic>Cystic Fibrosis - metabolism</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Ferritins - metabolism</topic><topic>Humans</topic><topic>Iron - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pneumology</topic><topic>Proteins - metabolism</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Smoking - adverse effects</topic><topic>Statistics, Nonparametric</topic><topic>Transferrin - metabolism</topic><topic>Tumor Cells, Cultured - metabolism</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STITES, S. W</creatorcontrib><creatorcontrib>PLAUTZ, M. W</creatorcontrib><creatorcontrib>BAILEY, K</creatorcontrib><creatorcontrib>O'BRIEN-LADNER, A. R</creatorcontrib><creatorcontrib>WESSELIUS, L. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STITES, S. W</au><au>PLAUTZ, M. W</au><au>BAILEY, K</au><au>O'BRIEN-LADNER, A. R</au><au>WESSELIUS, L. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>1999-09-01</date><risdate>1999</risdate><volume>160</volume><issue>3</issue><spage>796</spage><epage>801</epage><pages>796-801</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p < 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p < 0.005) or NS (9 +/- 3 ng/ml, p < 0.0005). Ferritin recovered from HS and NS lungs was < 2% H type, whereas ferritin in CF lungs was > 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth.</abstract><cop>New York, NY</cop><pub>American Lung Association</pub><pmid>10471599</pmid><doi>10.1164/ajrccm.160.3.9811018</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-449X |
ispartof | American journal of respiratory and critical care medicine, 1999-09, Vol.160 (3), p.796-801 |
issn | 1073-449X 1535-4970 |
language | eng |
recordid | cdi_proquest_miscellaneous_70009621 |
source | Journals@Ovid Complete - AutoHoldings; MEDLINE; American Thoracic Society Journals; EZB Electronic Journals Library |
subjects | Adult Biological and medical sciences Bronchoalveolar Lavage Fluid - chemistry Bronchoalveolar Lavage Fluid - cytology Cell Count Chronic Disease Cystic Fibrosis - metabolism Enzyme-Linked Immunosorbent Assay Female Ferritins - metabolism Humans Iron - metabolism Male Medical sciences Pneumology Proteins - metabolism Respiratory system : syndromes and miscellaneous diseases Smoking - adverse effects Statistics, Nonparametric Transferrin - metabolism Tumor Cells, Cultured - metabolism Tumor Necrosis Factor-alpha - metabolism |
title | Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A06%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20concentrations%20of%20iron%20and%20isoferritins%20in%20the%20lower%20respiratory%20tract%20of%20patients%20with%20stable%20cystic%20fibrosis&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=STITES,%20S.%20W&rft.date=1999-09-01&rft.volume=160&rft.issue=3&rft.spage=796&rft.epage=801&rft.pages=796-801&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/ajrccm.160.3.9811018&rft_dat=%3Cproquest_cross%3E70009621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70009621&rft_id=info:pmid/10471599&rfr_iscdi=true |